Clinical trial
EMEND® IV In Salvage Treatment of Chemotherapy-Induced Vomiting
NCT01405924 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EMEND® IV In Salvage Treatment of Chemotherapy-Induced Vomiting
- Lead sponsor
- Merck Sharp & Dohme LLC
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 25, 2011
- Completion date
- December 6, 2013
- Enrollment
- 111 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.